Who made the mRNA vaccine? Measuring division of labor in therapeutic innovationTo accelerate future vaccine development, understanding the longer-term funding dynamics behind recent successes such as the USA's Operation Warp Speed and the UK's Vaccine Taskforce is imperative....
In late July, the World Health Organization (WHO)announcedplans to develop a messenger RNA (mRNA) vaccine to protect people in low- and middle-income countries from the highly pathogenic avian influenza A(H5N1) virus. The initiative comes during continued concern about a public health ris...
Meanwhile, Dr. Ahmed Shahin, professor of virology at Zagazig University in Egypt, confirmed that granting these African countries the technology for the manufacture of mRNA vaccines will play a prominent role in the localization of vaccine and drug manufacturing technology in Africa, and help the i...
“This initiative exemplifies why WHO established the mRNA Technology Transfer Programme (TTP) — to foster greater research, development and production in low- and middle-income countries, so that when the next pandemic arrives, the world will be better prepared to mount a more effective and...
Her work at DuPont combined her childhood love of science and fabric with her interest in helping people and solving problems, and her creations would change the world.At DuPont, Stephanie invented Kevlar fiber. It’s five times stronger than steel. Kevlar fiber is now used in more than 200...
参考链接:https://www.who.int/publications/m/item/global-vaccine-market-report-2023 识别微信二维码,添加生物制品圈小编,符合条件者即可加入 生物制品微信群! 请注明:姓名+研究方向! 版 权 声 明 本公众号所有转载文章系出于传递更多信息之目的,且明确注明来源和作者,...
公共卫生投资的增加:预计全球将增加对公共卫生基础设施的投资,包括疫苗接种计划,以提高对未来疫情的准备和应对能力。 参考链接:https://www.who.int/publications/m/item/global-vaccine-market-report-2023 生物制品微信群! 请注明:姓名+研究方向! 版 权 声 明...
“Everyone who is seriously involved in the pursuit of science becomes convinced that some spirit is manifest in the laws of the universe, one that is vastly superior to that of man.” - Albert Einstein
there is currently no data whether humans who have recovered from SARS-CoV-2 infection are protected from re-exposure. This is a critical issue with profound implications for vaccine development, public health strategies, antibody-based therapeutics, and epidemiologic modeling of herd immunity. ___1...
implications for booster administration strategies in the context of the omicron variant," says Ranzani. They show that in individuals who initially received inactivated vaccines, heterologous boosting (in this case, with an mRNA vaccine) offers a substantial increase in protection, even in the ...